How Compugen Is Weathering Thursday’s Storm
Compugen shares pushed higher on Thursday after it was announced that Bristol-Myers Squibb will make a $12 million equity investment as part of its collaboration on a cancer trial.
All Work
Chris Lange
What to Look For in Wells Fargo’s Q3 Report
Wells Fargo is set to release its third-quarter financial results before the markets open on Friday, and analysts are looking for strong year-over-year earnings growth.
CRISPR Wins FDA Approval for Human Trials
CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration with Vertex Pharmaceuticals.
Why This Lithium IPO Was a Huge Disappointment
Livent shares disappointed investors when they entered the market on Thursday. The stock entered the market below the expected price range has only dropped lower as the day has gone on.
Why Square Is Getting Crushed
Square shares pulled back on Thursday after the company announced that there would be big changes at the top. Specifically, the chief financial officer is stepping down from this role.
What to Watch in JPMorgan Earnings Friday
JPMorgan is scheduled to release its latest quarterly results before the markets open on Friday, and analysts are looking for growth on the top and bottom lines.
What to Expect When Citigroup Reports Friday Morning
Citigroup is scheduled to reveal its third-quarter results early on Friday and analysts are looking for solid growth on the top and bottom lines.
Delta Q3 Earnings Take Flight
Delta Air Lines released better-than-expected quarterly results before the markets opened on Thursday.
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a very bad day for the broad U.S. markets. The broad markets each dropped over 3% in the session, making this one of the worst trading days of the year. Crude oil…
Anaplan Announces Potential Pricing for IPO
Connected planning pioneer Anaplan expects to price 15 million shares for an initial public offering valued up to about $303 million.
Why IDT Is Wednesday’s Big Earnings Winner
IDT shares soared after it released its fiscal fourth-quarter financial results and announced share buybacks.
Meet Ionis Pharma’s Newest Collaboration
Ionis Pharmaceuticals shares were relatively flat on Wednesday after the company announced a new collaboration with Roche to develop IONIS-FB-LRx for the treatment of complement-mediated diseases.
Why AcelRx Is Jumping Despite FDA Update
AcelRx shares made a solid gain on Wednesday despite a less-than-favorable update from the FDA. However, there is a vote for approval on Friday. and that seems to be what investors are optimistic about.
Short Sellers Up the Ante in Major Oil Stocks
The September 28 short interest data have been compared with the previous figures, and short interest in these selected big oil stocks increased.
Social Media Short Sellers Grow More Selective
Short interest in most of these selected social media stocks decreased as of the latest settlement date.
Short Sellers Run for Cover From Major Pharma
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
Major Semiconductor Short Sellers Can’t Make Up Their Minds
The September 28 short interest data have been compared with the previous report. Short interest in these selected semiconductor stocks was mixed.
Cybersecurity Stocks Scare Off Short Sellers
The September 28 short interest data have been compared with the previous figures, and short interest in most of these selected cybersecurity stocks decreased.
What Major Banks’ Short Interest Is Saying Ahead of Earnings
The September 28 short interest data have been compared with the previous figures, and short interest in most of these selected big bank stocks decreased.
Short Sellers Back Off Major Biotechs
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.